For the year ending 2025-12-31, QURE had -$78,527K decrease in cash & cash equivalents over the period. -$178,402K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -198,971 |
| Depreciation and amortization | 14,759 |
| Amortization of discount on investment securities | -10,463 |
| Share-based compensation expense | 17,679 |
| Royalty financing agreement interest expense, net of interest paid | 38,841 |
| Deferred tax expense | 1,588 |
| Changes in fair value of contingent consideration | 6,247 |
| Changes in fair value of liability related to pre-funded warrants | -12,405 |
| Unrealized foreign exchange (gains) / losses, net | 23,019 |
| Other items, net | 5,429 |
| Accounts receivable, prepaid expenses, and other current assets and receivables | 8,597 |
| Accounts payable | -2,667 |
| Accrued expenses, other liabilities, and operating leases | 4,474 |
| Net cash used in operating activities | -177,963 |
| Proceeds on maturity of debt securities | 337,195 |
| Investment in debt securities | 658,375 |
| Purchases of property, plant, and equipment | 439 |
| Net cash (used in) / generated from investing activities | -321,619 |
| Proceeds from follow-on public offerings of ordinary shares, net of issuance costs | 380,737 |
| Proceeds from issuance of pre-funded warrants, net of issuance costs | 23,499 |
| Proceeds from issuance of ordinary shares related to employee stock options and purchase plans | 11,162 |
| Net cash generated from / (used in) financing activities | 415,398 |
| Currency effect on cash, cash equivalents and restricted cash | 5,657 |
| Net (decrease) / increase in cash, cash equivalents and restricted cash | -78,527 |
| Cash, cash equivalents and restricted cash at the beginning of period | 160,329 |
| Cash, cash equivalents and restricted cash at the end of period | 81,802 |
uniQure N.V. (QURE)
uniQure N.V. (QURE)